Sitemap

Hemofarm: The Patient Must Not Suffer

CorD Recommends

European Parliament Passes Groundbreaking AI Law

The European Parliament has adopted the Artificial...

European Parliament Members Endorse Western Balkan Reform and Growth Instrument

Members of the European Parliament's committees on...

US Leads Global Oil Production for the Sixth Consecutive Year

The United States has maintained its position...

Balkan Borders Blur as Free Labor Movement Pact Launches

Marking a significant shift in the labor...

EU Passes Landmark Media Freedom Law

The European Council has adopted a groundbreaking law aimed at safeguarding media freedom, pluralism, and editorial independence within the...

Scholz Champions Western Balkans’ Path to Membership

German Chancellor Olaf Scholz, in Slovenia, advocated for quickening the EU accession for the Western Balkans, underlining the importance...

Wiener Städtische Insurance company is the winner of Dobročinitelj (Benefactor) award

The company Wiener Städtische Insurance received the Dobročinitelj (Benefactor) award for socially responsible activities implemented during 2021, 2022 and...

CEB Grants €1.3 Billion Loans to Boost Social Sectors in 11 Countries

The Council of Europe Development Bank (CEB) has sanctioned loans totaling €1.3 billion for 11 member countries, including Serbia...

Serbia Advances in Renewable Energy with Pupin Wind Park Financing

In a significant stride towards renewable energy adoption, Serbia has finalized the financial arrangements for the Pupin Wind Park,...

The company Hemofarm has organised the first regional expert conference entitled “Modern therapeutic approach to severely ill patients in hospital conditions”, gathering 250 of the most renowned experts from Serbia, the region and the world, and distinguished lecturers from Slovenia, Bosnia and Herzegovina, Serbia and the USA.

Through case studies, doctors of various specialties, anesthesiologists, doctors for infectious diseases, pulmonologists, emergency medicine specialists, surgeons and clinical pharmacologists were given the opportunity to exchange clinical experiences and approaches, become acquainted with therapeutic options and the choice of drugs in the countries of the region and beyond, and find out about the latest therapeutic options, with the sole aim of raising the quality and efficiency of treatment for the most serious patients in Serbia.

“Today a patient must not suffer. They all have the right, no matter how difficult or advanced the illness is, to spend their days in peace, not in suffering”, said Ronald Seelinger, Hemofarm CEO.

“This is not just a task for us whose main goal is to care for people’s health, but it is also a basic human right that must be respected.”

As the leading pharmaceutical company in the region, Hemofarm actively monitors trends in pain therapy with the goal of further completing an already wide range with the registration of new molecules, starting from treatment of milder forms of pain to those for the pain of the highest intensity, and thus contribute to the fight for the right of every patient to a dignified life without suffering.

Related Articles

Scholz Champions Western Balkans’ Path to Membership

German Chancellor Olaf Scholz, in Slovenia, advocated for quickening the EU accession for the Western Balkans, underlining the importance of reform-driven progress over geopolitical...

Serbia Poised to Drive Regional Growth, Says German Ambassador

Germany's Ambassador to Belgrade, Anke Konrad, has expressed optimism about Serbia's capacity for accelerated progress towards European Union membership, suggesting the nation could become...

India Set to Overtake Japan and Germany, Eyeing Third Spot in Global Economy by 2027

India is poised for a monumental economic leap, projected to surpass Japan and Germany to claim the title of the world's third-largest economy by...

The Foreign Investors Council held its Regular Annual Assembly

The Foreign Investors Council (FIC) held the regular annual session of the Assembly, adopting the Annual and Financial Reports for 2023. In his opening...

Brewing Trouble: Climate Change Impacts Key Ingredient for Beer

The production of popular beverages like coffee, tea, and wine is becoming increasingly difficult on a warming planet. Recent studies focusing on how climate...

£425M JUPITER: Europe’s Top Supercomputer in Making

A consortium comprising of Germany's Partec and France's Atos has announced their collaboration to develop Europe's inaugural supercomputer, JUPITER, capable of performing a quadrillion...

Comment

Moving Mountains

Bilateral relations between Serbia and Germany are marked by a strong partnership, particularly in the economic sphere. Even geopolitical crises, regional conflicts or high...

H.E. Anke Konrad, Ambassador Of Germany To Serbia

Berlin and Belgrade Remain Close

With the reform of the German citizenship law, the country’s federal government intends to create a modern immigration law that reflects the diversity of...